Open Access

Use of novel oral anticoagulants in patients with atrial fibrillation and moderate to severe renal dysfunction: findings from a prospective national registry

Congress Session

About the speaker

Professor Ilan Goldenberg

University of Rochester, Rochester (United States of America)
3 presentations
1 follower

6 more presentations in this session

Adherence to anticoagulant drugs in patients with atrial fibrillation and stroke in real clinical practice

Speaker: Professor D. Duplyakov (Samara, RU)

Thumbnail

Outcomes in vitamin K antagonist treated atrial fibrillation patients with stable international normalized ratios

Speaker: Doctor A. Nissen Bonde (Gentofte, DK)

Thumbnail

Periprocedural anticoagulation is associated with the risk of thromboembolism after elective cardioversion of atrial fibrillation.

Speaker: Doctor T. Hellman (Turku, FI)

Thumbnail

Reduced fibrin clot permeability is associated with an increased risk of both ischemic stroke and major bleeding in atrial fibrillation patients treated with vitamin k antagonists

Speaker: Professor A. Undas (Krakow, PL)

Thumbnail

The impact of age on the effectiveness and safety of the NOACs versus warfarin for stroke prevention in atrial fibrillation

Speaker: Doctor P. Noseworthy (Rochester, US)

Thumbnail

Access the full session

Progress in stroke prevention in atrial fibrillation

Speakers: Professor I. Goldenberg, Professor D. Duplyakov, Doctor A. Nissen Bonde, Doctor T. Hellman, Professor A. Undas...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk